Full-Time

Senior Manager

Business Development, Pharma & Life Sciences

Axle

Axle

201-500 employees

Translational research informatics and data science

Compensation Overview

$120k - $150k/yr

Vienna, VA, USA

In Person

Onsite in Tysons, VA five days per week.

Category
Business & Strategy (1)

Get referred to Axle

See people who can refer or advise you

Requirements
  • 5–8 years of experience in business development, consulting, or commercial roles within pharma, biotech, CROs, CDMOs, or life sciences technology organizations.
  • Demonstrated success selling services, data, or technology solutions into pharmaceutical or biotechnology clients.
  • Proven ability to build and convert pipeline quickly, closing complex, multi-stakeholder deals in regulated enterprise environments.
  • Strong working knowledge of pharma and life sciences operating environments, including R&D, clinical development, and data ecosystems.
  • Proven ability to independently build pipeline and advance complex, multi-stakeholder deals.
  • Comfortable engaging with scientific, technical, and business audiences.
  • Excellent communication, organizational, and relationship-building skills.
Responsibilities
  • Market Development & Client Engagement: Build, maintain, and monetize senior executive relationships across pharmaceutical manufacturers, CRO’s, medical device companies, health systems, and other healthcare ecosystem stakeholders.
  • Leverage an existing book of business and industry relationships to accelerate pipeline creation and early deal conversion.
  • Serve as a trusted advisor to client stakeholders on data-driven decision-making, analytics modernization, and technology-enabled transformation.
  • Independently identify, qualify, and pursue new commercial opportunities aligned to Axle’s core capabilities.
  • Develop deep understanding of client business models, regulatory environments, and operational pain points.
  • Act as a credible Axle representative in conversations with senior scientific and business stakeholders.
  • Business Development Execution: Own an individual revenue target and sales quota for insurance and financial services accounts.
  • Own the full sales lifecycle from initial outreach through deal close and expansion
  • Translate Axle’s scientific, data, and analytics capabilities into clear, outcome-driven value propositions.
  • Drive consultative selling efforts across Axle’s life sciences offerings, including data analytics, AI/ML, and scientific services.
  • Support pricing, proposal development, and contract negotiations in partnership with internal stakeholders.
  • Solution Positioning & Go-To-Market Support: Collaborate with technical leaders and SMEs to shape client-specific solutions and engagement models.
  • Provide real-time market feedback to refine Axle’s pharma go-to-market strategy and offerings.
  • Identify opportunities for repeatable solutions, partnerships, and account expansion.
  • Contribute to the development of client-facing materials and sales enablement content.
  • Client Success & Growth Enablement: Partner with delivery teams to ensure successful transition from sale to execution.
  • Maintain client relationships post-sale to support expansion, renewals, and long-term growth.
  • Monitor engagement health and proactively address risks or concerns.
  • Focus on building durable client relationships that drive sustainable growth.
Desired Qualifications
  • Hunter mentality with a strong bias toward action and execution.
  • Entrepreneurial mindset and comfort operating with limited structure.
  • Intellectual curiosity and willingness to deeply understand scientific and technical solutions.
  • High ownership, accountability, and drive for career progression.
  • Interest in growing into a Director-level role as the business scales.

Axle Informatics provides specialized informatics solutions for translational research, health informatics, and data science to biomedical research centers and healthcare organizations. Its offerings are customized software and data management platforms that help researchers collect, integrate, analyze, and visualize large research datasets, with end-to-end tools that automate data aggregation and deliver analytics, dashboards, and decision-support features. The company differentiates itself with an integrated, scientifically informed approach that bridges data science with application development, specifically focused on translational research and clinical data work rather than generic software. Axle’s goal is to advance public health by moving biomedical discoveries from the lab to bedside, improving healthcare outcomes.

Company Size

201-500

Company Stage

N/A

Total Funding

N/A

Headquarters

Rockville, Maryland

Founded

2002

Get referred to Axle

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • NIH awarded Axle the $11.2 million N3C Dynamic Workspaces task order on September 30, 2025.
  • NCATS extended Axle through June 27, 2026, signaling trust during transition risk.
  • SK pharmteco partnered with Axle and NIH on rare-disease gene therapy programs on May 7, 2026.

What critics are saying

  • Axle depends heavily on NIH funding; one recompete failure hits revenues by 2027.
  • NCATS limited-source notices in 2025-2026 show mission-critical work gets rebid fast.
  • A larger integrator like Dovel or Leidos can underprice Axle and compress margins.

What makes Axle unique

  • Axle embeds inside NIH, winning NCATS and NIAID support work in 2025-2026.
  • Its translational-research niche blends biomedical science, software engineering, and federal program management.
  • Repeated sole-source extensions show NIH treats Axle as operational infrastructure, not a commodity vendor.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Paid Vacation

Paid Holidays

401(k) Company Match

Educational Benefits for Career Growth

Employee Referral Bonus

Flexible Spending Accounts

Company News

TheGWW.com
Jul 25th, 2023
“Octo awarded $64.7M IT Infrastructure Call Order to support NCI’s Cancer research”

Octo, in partnership with Unissant, Axle Informatics, and TRex, has been awarded an IT Infrastructure and Operations Call Order to support the NCI’s OCIO.

GlobeNewswire
Jan 12th, 2023
Digital Pathology Market Worth $1.86 Billion by 2030 -

For instance, in May 2020, Indica Labs (U.S.), a provider of digital pathology solutions, collaborated with information technology consulting companies, Octo (U.S.) and Axle Informatics (U.S.) and the National Institutes of Health (NIH) (U.S.), to develop an online collection of high-resolution histopathology images of tissues from COVID-19 patients using Indica’s HALO Link platform.